The lipoxin A~4~receptor (ALXR) is expressed in fibroblast-like synoviocytes and is targeted by both antiinflammatory and proinflammatory endogenous ligands. Recently, annexin-1 (lipocortin) has been identified to be an ALXR ligand. Uteroglobin (Ug) is secretoglobin that shares with annexin-1 properties such as potent inhibition of phospholipase A~2~(PLA~2~) as well as sequence similarities in the \'antiflammin\' consensus region. Potential receptor interactions of Ug with ALXR were therefore investigated and PLA~2~activity assays were performed in CHO and HL-60 cell lines stably overexpressing ALXR. Serum amyloid A (SAA), an ALXR ligand displaying proinflammatory activities, was compared with two antiinflammatory ligands, Ug and lipoxin A~4~(LXA~4~). While Ug and LXA~4~did not alter baseline PLA~2~activity (Ug) or provoked a pulsed peak of activity (LXA~4~), SAA did induce a delayed and prolonged activation of PLA~2~. SAA-induced PLA~2~activation was sharply inhibited in the presence of Ug. Ug inhibition of SAA-dependent phospholipase activity occurred at submillimolar Ca^2+^concentrations, suggesting an effect on cytosolic PLA~2~(rather than secretory PLA~2~, a known target inhibited by Ug and annexin-1 but requiring millimolar Ca^2+^). Studies of Erk, p38 and AKT kinase phosphorylation confirmed that SAA and Ug interact with ALXR to oppositely regulate GPCR-coupled downstream signaling events. Overall the analysis of phospholipase D activity, kinase phosphorylation and cAMP levels also suggested that proinflammatory and antiinflammatory ligands of ALXR engage differently coupled pathways, leading to activation of these processes (SAA) or to their inhibition (LXA~4~and Ug). These signaling events are functionally matched by the ability of SAA to stimulate NF-κB activity, IL-8 release and cell chemotaxis, and that of LXA~4~and Ug to strongly inhibit them. Expression of Ug and SAA mRNAs was also detected in human fibroblast-like synoviocytes, suggesting that ALXR may play a pivotal role in the pathophysiology of arthritis. In addition, annexin-1 and Ug inhibition of PLA~2~offers enticing new venues to control inflammatory arthritides by limiting, for example, cascade signaling amplification via synthesis of proinflammatory eicosanoids, along with a redirection of ALXR signaling toward antiinflammatory feedback mechanisms.
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